PMN

ProMIS Neurosciences Inc. Common Shares (ON)

$10.41 -3.70%

Recent alerts on PMN

All signals →

SEC filing PMN Elects 7 Directors, Approves $900K Share Increase to 2025 Stock Option Plan, Ratifies Baker Tilly US as Auditor

Insider trade Purchase by Patrick D. Kirwin

Insider trade Purchase by Patrick D. Kirwin

SEC filing PMN Reports $0 Revenue, $0 EPS, Announces $175M Financing, PMN310 Phase 1b Enrolled 144 Patients, Fast Track Designation, No SAEs, Top-Line Data 2027

Insider trade Purchase by Eugene Williams

Insider trade Purchase by Eugene Williams

Insider trade Purchase by Johanne Kaplan (Chief Development Officer)

Insider trade Purchase by ABG Management Ltd. / Ally Bridge MedAlpha Master Fund L.P. / Ally Bridge Group (NY) LLC / Yu Fan / Slanix Paul Alex

SEC filing 8-K Filing

Scanner Unusual volume (5.2x average)

Get push alerts for PMN

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS